Abstract
The expression of TGF-alpha in human colon and lung carcinoma cell lines has been reported previously, but its expression in primary tumours has not been described in detail. We have used the radio-immunoassay method to measure the specific content of immunoreactive TGF-alpha in the acid ethanol extracts of normal and cancerous tissues of human colon and lung. The average TGF-alpha content of colon carcinomas is 4 times that of the normal mucosa, and for non-small cell lung carcinomas it is twice that of the normal parenchyma. Because of variability in the TGF-alpha expression among individuals and in different segments of colon and lobes of lung, the ratio of TGF-alpha content of paired tumour and normal tissue was also calculated. On average, the tumour/normal ratio for colon carcinoma is higher than that for lung carcinoma. Although 55% of colon tumours show a ratio 4 times, or greater, only 33% of lung carcinomas demonstrate this ratio. The level of TGF-alpha in both colon and lung carcinomas does not correlate with histological type stage, grade nor degree of desmoplasia of these tumours. Northern blot analysis of total cellular RNA confirms the expression of an approximately 4.8 kb TGF-alpha mRNA in normal colonic mucosa and lung parenchyma. However, in contrast to the results of radio-immunoassay, significant over-expression of TGF-alpha mRNA is uncommon in primary human colon carcinomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, C., Woo, A. & Tsao, MS. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas. Br J Cancer 62, 425–429 (1990). https://doi.org/10.1038/bjc.1990.311
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.311
This article is cited by
-
TGF-alpha as a candidate tumor antigen for renal cell carcinomas
Cancer Immunology, Immunotherapy (2009)
-
Activation of the TGFα autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells
Oncogene (2002)
-
TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
Gene Therapy (2000)
-
Increased serum levels of transforming growth factor- α in patients with colorectal cancer
Diseases of the Colon & Rectum (1998)
-
Immunolocalization of transforming growth factor alpha in normal human tissues
Histochemistry and Cell Biology (1996)